Thomas P. Flynn - Concepedia

Author

Thomas P. Flynn

Also Known As

T P Flynn, T. Flynn, T. P. Flynn, Thomas Flynn, Thomas P. Flynn

Publications

285

Citations

H-Index

Concepts

All Affiliations

Thomas P. Flynn is an author at United States Department of Veterans Affairs specializing in medicine, health sciences, and oxidative stress.

#	Concept	H-Index	Publications	Citations
1	Health Sciences	3	3	204
2	Medicine	3	3	204
3	Biochemistry	2	2	155
4	Metabolism	2	2	155
5	Cellular Physiology	1	1	63

Thomas P. Flynn

Publications

273

Citations

H-Index

Page 1

	Year	Citations
Oxidant damage of the lipids and proteins of the erythrocyte membranes in unstable hemoglobin disease. Evidence for the role of lipid peroxidation. Thomas P. Flynn, David W. Allen, G. J. Johnson, Journal of Clinical Investigation Lipid PeroxidationLipid ExtractsIron DeficiencyOxidant DamageRedox Biology	1983	92
Decreased survival in vivo of diamide-incubated dog erythrocytes. A model of oxidant-induced hemolysis. G. J. Johnson, David W. Allen, Thomas P. Flynn, Journal of Clinical Investigation Redox BiologyCellular PhysiologyMembrane Specific GravityOxidative StressLaboratory Hematology	1980	63
Thrombotic thrombocytopenic purpura in a human immunodeficiency virus (HIV)‐seropositive homosexual man Janet A. Jokela, Thomas P. Flynn, Keith Henry American Journal of Hematology	1987	57
Results of a Phase II Multicenter Trial of Single-Agent Gemcitabine in Patients with Relapsed or Chemotherapy-Refractory Hodgkin's Lymphoma Hemachandra Venkatesh, Nicholas Di Bella, Thomas P. Flynn, Clinical Lymphoma Lymphoid NeoplasiaMedicineSingle-agent GemcitabineClinical TrialsChemotherapy-refractory Hodgkin	2004	49
Phase II trial combining nab-paclitaxel (NP), gemcitabine (G), and bevacizumab (B) in patients (pts) with metastatic breast cancer (MBC): NCCTG N0735. Donald W. Northfelt, A. C. Dueck, Thomas P. Flynn, Journal of Clinical Oncology	2011	12

Page 1